Drugs / 0.1% FML
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06209879 Background | Feb → Dec 2024 | dry eye syndrome | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 0.1% FML | “0.1% FML” NCT06209879 ↗ |
| Known as | FML | “0.1% FML (1-2 drops 3 times a day) in both eyes for 12 week” NCT06209879 ↗ |
| Route | Topical | “0.1% FML (1-2 drops 3 times a day) in both eyes for 12 week” NCT06209879 ↗ |